Central Hospital
Nancy, Vandoeuvre Lès Nancy, 54500, France
NCT Number: NCT06068595
The hypothesis of this study is that musculoskeletal point of care ultrasonography would support the GP's decision and ultimately improve patient management.
The aim of this study is to evaluate, in the context of suspected musculoskeletal abnormality, the contribution of musculoskeletal point of care ultrasonography to the general practitioner's overall decision-making strategy, defined according to the following 5 axes: diagnosis (I), therapy (II), patient orientation (III), prescription of complementary examinations (IV) and follow-up (V).
Trial opening soon.
Get NotifiedAll sexes
Interventional
Not applicable
Nancy, Vandoeuvre Lès Nancy, 54500, France
The study circuit takes place in a single visit.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
After clinical examination and medical interrogation, The investigating physician gives her decisions in the e-CRF according to the 5 axes: diagnosis (I), therapy (II), patient referral (III), prescription of additional tests (IV) and follow-up (V). The investigator performs the targeted musculoskeletal ultrasound with his personal ultrasound machine, following his usual operating procedure and give/keep the final diagnostic.
Time frame: 3 years
Percentage of patients for whom the musculoskeletal point of care ultrasonography led to a change in the GP's overall decision-making strategy (binary yes/no variable) of patients for whom led to a change in the GP's overall decision-making strategy (binary yes/no variable)
Time frame: 3 years
Frequency of the different anatomical sites (shoulder, elbow, arm, etc.) and structures (osteoarticular pathologies, tendon and retinacular pathologies, etc.) concerned
Time frame: 3 years
Frequency of different modifications for each axis and within each axis
Time frame: 3 years
List and frequency of diagnoses in the case of post-CTA confirmation
Time frame: 3 years
List and frequency of diagnoses in the case of post-CTA modifications
Time frame: 3 years
Frequency and description of incidental diagnoses discovered at CTA
Time frame: 3 years
Frequency of different modifications for each axis and within each axis per patient
Time frame: 3 years
Calculation of the cost before and after CTA estimated a posteriori on the basis of the consultation rate
Time frame: 3 years
the rates for the examinations and therapies described
Time frame: 3 years
For each doctor: the frequency with which CTA is carried out in his professional practice
Time frame: 3 years
For each doctor: the time taken to carry out the CTA
Time frame: 3 years
For each doctor: the average number of ultrasound image prints
Time frame: 3 years
For each doctor: the time taken to produce an CTA report
Contact information is provided by the study sponsor or research team.
Central Hospital, Nancy, France
Other
The Contribution of Targeted Musculoskeletal Ultrasound to the General Practitioner's Overall Decision-making Strategy for Patients With Suspected Musculoskeletal Pathology: a Before/After Study
Acronym: ECHOSTEOM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07661485
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Faisalābad, Punjab Province, Pakistan
View Trial DetailsNCT07190118
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Gaziantep, Turkey (Türkiye)
View Trial DetailsNCT06996158
Arthritis, Congenital Abnormalities
View Trial DetailsNCT07154719
Body Weight, Bone Diseases
Baton Rouge, Louisiana, United States
View Trial Details